Armata Pharmaceuticals (ARMP) Notes Payables (2016 - 2023)
Quarterly results put Notes Payables at $26.4 million for Q2 2023, changed N/A from a year ago — trailing twelve months through Jun 2023 was $26.4 million (changed N/A YoY), and the annual figure for FY2016 was $803000.0, changed.
Armata Pharmaceuticals has reported Notes Payables over the past 3 years, most recently at $26.4 million for Q2 2023.
- Notes Payables reached $26.4 million in Q2 2023 per ARMP's latest filing, down from $32.4 million in the prior quarter.
- Across five years, Notes Payables topped out at $32.4 million in Q1 2023 and bottomed at $26.4 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 26.35 Mn |
| Mar 31, 2023 | 32.39 Mn |
| Sep 30, 2017 | 305,000.00 |
| Jun 30, 2017 | 606,000.00 |
| Mar 31, 2017 | 598,000.00 |
| Dec 31, 2016 | 803,000.00 |